Microbix Biosystems Inc. (TSE:MBX – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$0.33 and traded as high as C$0.39. Microbix Biosystems shares last traded at C$0.34, with a volume of 167,786 shares traded.
Microbix Biosystems Stock Down 1.5 %
The company has a debt-to-equity ratio of 24.53, a quick ratio of 5.57 and a current ratio of 8.53. The stock has a market capitalization of C$46.04 million, a PE ratio of 11.17 and a beta of 0.25. The business has a 50 day moving average of C$0.33 and a two-hundred day moving average of C$0.37.
Microbix Biosystems Company Profile
Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.
Featured Stories
- Five stocks we like better than Microbix Biosystems
- Investing in Commodities: What Are They? How to Invest in Them
- Sarepta Therapeutics Stock Soars on FDA Approval
- Industrial Products Stocks Investing
- CarMax: A Market Melt-Up Waiting to Happen for this Stock
- Energy and Oil Stocks Explained
- 3 Solar Stocks to Watch that are Building the Green Energy Future
Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.